Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
DRREDDY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Reddy's Laboratories has informed the stock exchanges that a meeting of its Board of Directors is scheduled for Wednesday, July 23, 2025. The primary agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter ending June 30, 2025 (Q1 FY26). In line with SEBI insider trading rules, the trading window for the company's securities will be closed from June 24, 2025, to July 25, 2025, covering the period around the results announcement. This is a standard regulatory disclosure required before quarterly earnings are released. The filing is signed by the Company Secretary and Compliance Officer.
This is a routine compliance filing with no direct impact on the stock. However, the upcoming Q1 FY26 results on July 23, 2025, could trigger short-term price movement depending on the numbers, and the trading window closure reminds investors that insiders are restricted from trading during this period.